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Sos1 and Sos2 are ubiquitously expressed, universal Ras guanine nucleotide exchange factors (Ras-GEFs) acting in multiple sig-
nal transduction pathways activated by upstream cellular kinases. The embryonic lethality of Sos1 null mutants has hampered
ascertaining the specific in vivo contributions of Sos1 and Sos2 to processes controlling adult organism survival or development
of hematopoietic and nonhematopoietic organs, tissues, and cell lineages. Here, we generated a tamoxifen-inducible Sos1-null
mouse strain allowing analysis of the combined disruption of Sos1 and Sos2 (Sos1/2) during adulthood. Sos1/2 double-knockout
(DKO) animals died precipitously, whereas individual Sos1 and Sos2 knockout (KO)mice were perfectly viable. A reduced per-
centage of total bone marrow precursors occurred in single-KO animals, but a dramatic depletion of B-cell progenitors was spe-
cifically detected in Sos1/2 DKOmice. We also confirmed a dominant role of Sos1 over Sos2 in early thymocyte maturation, with
almost complete thymus disappearance and dramatically higher reduction of absolute thymocyte counts in Sos1/2 DKO ani-
mals. Absolute counts of mature B and T cells in spleen and peripheral blood were unchanged in single-KOmutants, while sig-
nificantly reduced in Sos1/2 DKOmice. Our data demonstrate functional redundancy between Sos1 and Sos2 for homeostasis
and survival of the full organism and for development andmaturation of T and B lymphocytes.
Ras proteins are critical signal transduction regulators whichcontrol cell proliferation, differentiation, and survival. These
small GTPases are continuously cycling between inactive (Ras-
GDP) and active (Ras-GTP) conformations in a process modu-
lated by both negative (i.e., GTPase-activating protein [Ras-GAP])
and positive (i.e., guanine nucleotide exchange factor [Ras-GEF])
cell regulators. Among the Ras-GEF families identified in mam-
mals, the Sos proteins are themost widely expressed and function-
ally relevant for Ras activation by upstream cellular signals (1, 2, 3,
4, 5).
The Sos family of Ras-GEFs encompasses two highly homolo-
gous members, Sos1 and Sos2 (Sos1/2), which are ubiquitously
expressed and function inmultiple signaling pathways promoting
Ras activation downstream of a wide variety of tyrosine kinase
receptors, as well as some cytokine and G protein-coupled recep-
tors (4). Despite their structural homology, the functional prop-
erties of Sos1 and Sos2 appear to be markedly different. Prior
analyses of constitutive knockout (KO) strains showed that Sos1
constitutive null animals die during midembryonic gestation (6),
whereas adult Sos2 knockout mice are perfectly viable and fertile
(7). The characterization of isolated Sos1 and Sos2 KO mouse
embryonic fibroblasts also revealed a critical requirement for Sos1
but not Sos2 for transformation by upstream tyrosine kinases and
for maintenance of long-term Ras–mitogen-activated protein ki-
nase (Ras-MAPK) activation (6). The generation of conditional
Sos1 null mutants (8) makes it now possible to address previously
unanswered questions regarding the viability of adultmice follow-
ing systemic deletion of Sos1 and the functional specificity versus
redundancy of Sos1 and Sos2 in specific cell lineages and tissues.
Depending on the cellular context, Ras-mediated signaling
controls a wide variety of biological, developmental, and onco-
genic processes (9). In hematopoietic cells, activated Ras proteins
are known to play a critical role in lymphocyte signaling processes
involved in various T- and B-cell maturation steps (10, 11, 12, 13).
Regarding B-cell development, various lines of experimental evi-
dence suggest that Sos proteins, together with Ras guanyl nucle-
otide-releasing protein (RasGRP), play significant roles in Ras-
mediated signaling downstream of epidermal growth factor
receptor (EGFR) and B-cell receptor (BCR) stimulation (12, 14,
15). Maturation of thymocytes has also been shown to involve the
participation of Ras signaling pathways through the coordinated
contribution of different Ras-GEFs such as Sos1 and RasGRP1 (8,
12, 14, 16, 17). In this context, it has been suggested that Sos
upregulation resulted in elevated risk of developing hematological
malignancies, especially juvenile myelomonocytic leukemia (4,
18, 19). Altogether, these observations support a critical role for
Sos familymembers during lymphocytematuration in the thymus
and the spleen and warrant further analysis of the specific contri-
bution of Sos1 or Sos2 to these developmental processes.
Here, we evaluate the functional significance of Sos1 and Sos2
in a genetically modified mouse model which is able to bypass the
known embryonic lethality of homozygous Sos1 nullmutantmice
(6). To this end, a floxed Sos1 allele (8) was placed under the
control of a tamoxifen (TAM)-inducible Cre in order to try and
achieve systemic, full-body deletion of the targeted Sos1 gene.
This conditional Sos1 knockout mouse strain was then bred to
constitutive Sos2 KO mice to generate experimental sets of wild-
Received 7 August 2013 Returned for modification 10 September 2013
Accepted 12 September 2013
Published ahead of print 16 September 2013
Address correspondence to Eugenio Santos, esantos@usal.es.
Copyright © 2013, American Society for Microbiology. All Rights Reserved.
doi:10.1128/MCB.01026-13
4562 mcb.asm.org Molecular and Cellular Biology p. 4562–4578 November 2013 Volume 33 Number 22
type (WT), Sos1 and Sos2 single-KO, and Sos1/2 double-KO
(DKO) animals. Despite the embryonic lethality of constitutive
Sos1 KO mice, adult animals expressing the conditionally floxed
Sos1 gene were fully viable, whereas absence of both Sos isoforms
caused precipitous death in the Sos1/2 DKO mutants associated
with marked reduction in lymphopoiesis, indicating that expres-
sion of either Sos1 or Sos2 alone is required and sufficient to sup-
port full viability of adult mice and that the Sos1 and -2 isoforms
play essential, redundant but also distinct roles in controlling the
development and homeostasis of the T- and B-cell lineages.
MATERIALS AND METHODS
Generation of tamoxifen-inducible, Sos1 null mutant mice. A mouse
strain harboring a floxed version of Sos1 with exon 10 flanked by LoxP
sites (Sos1fl/fl) (8) was crossed with mice expressing a TAM-inducible
Cre recombinase downstream of the RERT (Jackson Laboratories;
stock number 017585, expressing an inducible Cre-ERT2, Cre recom-
binase fused to a triple mutant form of the human estrogen receptor,
from the endogenous Polr2a locus) promoter to generate homozygous
Sos1fl-Cre/Sos1fl-Cre mice that were then mated with constitutive Sos2
null mutant mice (Sos2/) (7). Resulting heterozygous Sos1fl-Cre//
Sos2/ mice were subsequently interbred to generate four distinct
genotypes, analyzed in this report: control (Sos1-Cre/-Cre/Sos2/),
Sos1 single-KO (Sos1fl-Cre/Sos1fl-Cre), Sos2 single-KO (Sos1-Cre/-Cre/
Sos2/), and Sos1/2 DKO (Sos1fl-Cre/fl-Cre/Sos2/) (see Fig. 1A). All
experimental groups were treated with TAM (after weaning the litters)
under identical conditions to exclude any possible off-target effects. As
TAM is an antagonist of the estrogen receptor, a 10-day washout period
habituation with a soy-free diet (Teklad 16% global protein rodent diet,
catalog no. 2916;Harlan)was given to the animals prior to the actual TAM
treatments. Afterwards, a TAM-containing chow diet (Harlan; Teklad
CRD TAM400/CreER) was administered, and experimental determina-
tions were performed on each specific set of control and KO animals at
various time points, most frequently at days 6 (6 days after initiating
TAM treatment), 9, and 12. TAM treatment for shorter periods (4
days) triggered systemic, whole-body Cre recombinase activation and
progressive removal of floxed Sos1 exon 10, which was 100% completed
after 12 days, as detected by PCR assays with specific primers (see Fig. 1B)
orWestern immunoblots with specific antibodies (see Fig. 1C). For geno-
typing, DNA from mouse tails was investigated by PCR using specific
primers to detect Sos1 or Sos2 deletion (7, 8). The animals were kept,
handled, and sacrificed in accordance with current European and Spanish
legislation, and all experiments were approved by the Bioethics Commit-
tee of our Cancer Research Center.
Phenotypic examinations. The Hemavet 950 instrument (Drew Sci-
entific, Dallas, TX) was used to determine a wide range of hematological
cell counts and other parameters in peripheral blood (PB) samples ob-
tained from defined experimental groups of male mice treated with TAM
for 12 days. Various biochemical parameters in blood serum from differ-
ent experimental groups of animals treated with TAM for 14 days were
also determined using reagent strips (total bilirubin, Panel-2, Panel-V,
and Heart-2 test strips; Menarini Diagnostics, Barcelona, Spain) quanti-
fied on the Spotchem EZ 4430 instrument (Menarini Diagnostics).
Histological analyses. For histological examination, mice were per-
fused with a fixative solution as described elsewhere (20). The tissues of
interest were dissected, postfixed for 2 h, and washed in phosphate buffer.
Tissue blocks were then dehydrated and paraffin embedded. Paraffin sec-
tions (3 m thick) were mounted on Superfrost-Plus slides (Thermo Sci-
entific, Limburg, Germany) and deparaffinized with xylene, followed by
decreasing concentrations of ethanol and distilled water. Hematoxylin-
eosin (H&E) staining and the terminal deoxynucleotidyltransferase-me-
diated dUTP-biotin nick end labeling (TUNEL) assay were performed
using standard procedures.
Western immunoblotting studies. Protein lysates were prepared by
sample homogenization in a lysis buffer as previously described (21).
Overall, 30 g of total protein per sample lane was applied to 10% poly-
acrylamide gels, resolved by SDS-PAGE, and electrophoretically trans-
ferred to polyvinylidene difluoride (PVDF) membranes. After being
blocked with 5% nonfat milk for 45 min at room temperature, the mem-
branes were incubated overnight with a mouse anti-Sos1 monoclonal
antibody (clone 25/SOS1; Becton Dickinson Biosciences [BD], San Jose,
CA) and rabbit anti-Sos2 polyclonal antibody (sc-258; Santa Cruz Bio-
technology, Dallas, TX) at 4°C. The membranes were then rinsed in 0.5%
phosphate-buffered saline (PBS)–Tween (3 times for 5min each), and the
corresponding secondary antibodies (dilution of 1:5,000) were applied at
room temperature for 1 h. After being washed with 0.5% PBS-Tween, the
membranes were resolved using the Odyssey instrument (LI-CORBiosci-
ences, Bad Homburg, Germany).
Flow cytometry immunophenotyping. PB and bone marrow (BM)
samples as well as cell suspensions from fresh,mechanically disaggregated
thymi and spleens of mice from all experimental groups were obtained.
Briefly, 2 106 cells per samplewere incubated in the dark for 30minwith
specific mixtures of fluorochrome-conjugated antibodies (Table 1) rec-
ognizing specific cell populations of interest in the thymus, BM, spleen,
and PB. Stained samples were then centrifuged (250  g, 5 min) and
washed in 0.5 ml of PBS. Finally, 1  106 cells were acquired using the
FACS Diva software (BD) in a FACSAria flow cytometer (BD). For data
analysis, the Infinicyt software (Cytognos SL, Salamanca, Spain)was used.
Bone marrow transplantation. Four distinct experimental groups
were examined: controlmouse recipients receivingWTBMcells (control/
control; n 7); control mice receiving DKOBM cells (control/DKO; n
10); DKO mice receiving control BM cells (DKO/control; n  7), and
DKO mice receiving DKO BM cells (DKO/DKO; n 7). Procedures for
BM transplantation were as previously described (22). Briefly, control or
DKO BM cells were isolated from 6-week-old female donors by flushing
tibias, femurs, and iliac crests with Dulbecco’s modified Eagle medium
(Invitrogen). Red blood cells were then lysed through incubation for 5
min in ice-cold ammonium chloride (140 mM in 17 mM Tris). After a
double wash with PBS and mild centrifugation, 7.5  106 BM cells were
injected intravenously into the tail veins of 20-day-oldWTandDKOmale
mouse receptors. Recipient animals had been sublethally irradiated (7.5
Gy; Gammacell 1000 Elite with cesium 137 source operating at 243 cGy/
min; Best Theratronics, Canada) to remove their own BM 24 h before
TABLE 1 List of fluorochrome-conjugated monoclonal antibodies used
in the present study for flow cytometry immunophenotyping
Antibodya Clone Source
Anti-CD3ε–PerCP–Cy5.5 145-2C11 BDb
Anti-CD4–APC–H7 GK1.5 BD
Anti-CD5–V450 53-7.3 BD
Anti-CD8a–PO 5H10 Invitrogenc
Anti-CD11b–PerCP–Cy5.5 M1/70 BD
Anti-CD19–APC–H7 1D3 BD
Anti-CD21/CD35–APC 7G6 BD
Anti-CD23–PE B3B4 BD
Anti-CD24–FITC M1/69 BD
Anti-CD25–PE–Cy7 PC61 BD
Anti-CD44–APC IM7 BD
Anti-CD45R (B220)–PO RA3-B62 Invitrogen
Anti-c-Kit (CD117)–APC 2B8 BD
Anti-IgD–V450 11-26c.2a BD
Anti-IgM–PE–Cy7 clone R6-60.2 BD
Anti-TCR chain–PE H57-597 BD
Anti-TCR–FITC GL3 BioLegendd
a APC, allophycocyanin; PO, Pacific Orange; PE, phycoerythrin; FITC, fluorescein
isothiocyanate.
b BD, Becton Dickinson Biosciences, San José, CA.
c Paisley, United Kingdom.
d San Diego, CA.
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FIG 1 Generation and phenotypic characterization of single and double Sos null mutant mice. (A) Schematic outlining of the generation of Sos1 and -2 and
Sos1/2 null mice. (B) PCR amplification of DNA extracted from the tails of control and Sos1fl/fl mice. Partial excision of Sos1 exon 10 was visible at day4, and
complete exon 10 removal was accomplished after 12 days of TAM treatment. (C)Western blot showing Sos1 depletion in isolated cells from Sos1 KO and Sos1/2
DKO mice before () or after () 12 days of TAM treatment. (D) Photographs of euthanized mice from all experimental groups. Control and Sos single-KO
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grafting.Once transplanted, recipient animals were treatedwith a soy-free
diet for 15 days, followed by 12 days of TAM administration through the
diet. Nontransplanted, irradiated recipients were used as controls for suc-
cessful irradiation. All irradiated nontransplanted mice died around 10
days after radiation.
Statistical methods. For all statistical analysis the SPSS v20 software
package (SPSS Inc., Chicago, IL) was used. TheMann-WhitneyU test was
used to evaluate the statistical significance of differences among different
animal groups. Survival curves were plotted according to the method of
Kaplan andMeier and compared by the log rank test. P values0.05 were
considered statistically significant.
RESULTS
Simultaneous disruption of Sos1 and Sos2 causes adult lethal-
ity, whereas Sos1 or Sos2 single-knockout mice are viable. In
order to test the viability of adult mice lacking Sos1, alone or
combinedwith loss of Sos2,we produced aTAM-inducible, floxed
Sos1 null mutant strain and crossed it with constitutive Sos2 KO
mice. Analysis of the resulting live offspring after TAM treatment
for disruption of the floxed Sos1 allele allowed recognition of four
specific genotypes: wild type, Sos1 single-KO, Sos2 single-KO, and
Sos1/2 DKO. These four genotypes were instrumental for ascer-
taining the functional specificity versus redundancy of the Sos1
and -2 isoforms as regards the sustainability of the viability and
survival of the full organism and/or their impact on distinctive
phenotypes in specific organs or cell lineages within these animals
(Fig. 1A).
Overall, our results showed that single Sos1 deficiency alone
during adulthood did not result in any obvious, external pheno-
typic alteration, as these animals showed full viability; similarly,
the absence of Sos2 did not cause any observable alterations com-
mice displayed normal phenotype, while the TAM-treated Sos1/2 DKOmouse was undersized and exhibited hunching of the spine. (E) Body weight measure-
ments at different stages, including after weaning (AW), after habituation diet (AH), and at various times (days 7 to 14) during TAM treatment. (F) Kaplan-Meier
survival plot showing that single Sos1 or Sos2 disruption did not compromise mouse survival (green line) while Sos1/2 DKO mutants died 2 weeks after TAM
induction (red line). (G) Photographs of thymi (left) and spleens (right) of WT and Sos1/2 DKOmice at day 14 after TAM induction. In Sos1/2 DKOmice, the
thymus almost disappeared while the spleen was undersized versusWT controls. (H and I) Bar charts representing the ratios between the weights of the thymus
or spleen per gram of total body weight (b.w) for all experimental mouse groups after 6, 9, and 12 days of TAM treatment. The weight of the thymus was
significantly reduced in Sos-null mice at all periods of time examined versus controls (H). In addition, at days 9 and 12 after TAM treatment, the thymi of Sos1/2
DKOmice were diminished versus those of Sos singlemutants (H). Data from the spleen revealed reduced weights in both Sos2 and doublemutants with respect
to controls (I). (J to M) Paraffin sections from spleens and thymi of control and Sos1/2 DKO mice at day 12 after TAM feeding, stained with hematoxylin and
eosin (H&E). The histology of the spleen appeared altered, with highly disrupted germinal centers in the DKO mice (K). In the thymus, Sos1/2 DKO mice
exhibited a marked reduction of the cortex (M). (N to Q) Terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling (TUNEL) assays
performed in paraffin sections from spleens and thymi of control and Sos1/2 DKOmice at day 12 after TAM treatment showed increased numbers of apoptotic
cell bodies both in the spleens (O) and the thymi (Q) fromSos1/2DKOmice versusWT controls (N andP). ,P	 0.05 versus control; ,P	 0.01 versus control
mice; #, P	 0.05 versus the rest of the groups; ##, P	 0.01 versus the rest of the groups (n 25 for all different genotypes analyzed). Bars, 1 mm.
TABLE 2 Hematological and biochemical parameters from peripheral blood and serum of control and Sos single and double null mutant mice
Parameter
Valuea (mean
 SD) for group:
Control Sos1/2 DKO Sos1 KO Sos2 KO
White blood cells/l (103) 4.8
 1.4 2
 0.5* 4.5
 1.3 3.3
 0.4
Neutrophils (%) 22
 4 29
 5 23
 5 25
 3
Lymphocytes (%) 70
 2 49
 4** 64
 7 63
 3
Monocytes (%) 7.7
 2.3 17.5
 3.7* 11.7
 3.6 10.5
 1.6
Eosinophils (%) 0.5
 0.4 4.9
 3.6* 1.4
 1 0.6
 0.5
Basophils (%) 0.08
 0.12 0.1
 0.08 0.25
 0.35 0.07
 0.08
Red blood cells/l (106) 8
 0.7 8.7
 0.2 8
 1 8.7
 0.5
Hemoglobin (g/dl) 13
 1 13
 0.5 14
 0.6 13.7
 0.6
Platelets/l (103) 907
 76 1,678
 178** 692
 163§ 1,106
 167#
Total protein (g/dl) 5
 1 3.1
 0.7** 4.3
 0.4 4.5
 0.4
Albumin (g/dl) 2.4
 0.2 1.5
 0.3** 2.1
 0.3 2.3
 0.1
Alkaline phosphatase (IU/liter) 488
 80 201
 69** 622
 185 481
 54
Creatine phosphokinase (IU/liter) 781
 315 1,424
 533* 780
 293 772
 232
Glutamic-oxaloacetic transaminase (IU/liter) 76
 17 419
 194** 66
 15 57
 19
Glutamate pyruvate transaminase (IU/liter) 39
 8 254
 91** 29
 11 33
 12
Lactate dehydrogenase (IU/liter) 975
 335 2,116
 629** 986
 499 938
 357
Creatinin (mg/dl) 0.5
 0.1 0.2
 0.1** 0.5
 0.1 0.5
 0.1
Blood urea nitrogen (mg/dl) 23
 5 40
 13 27
 6 24
 6
Uric acid (mg/dl) 3.7
 0.7 2.5
 1.2 2.7
 1 2.3
 1
Triglyceride (mg/dl) 78
 16 76
 46 87
 17 93
 38
Cholesterol (mg/dl) 80
 10 72
 15 66
 18 77
 17
Glucose (mg/dl) 100
 27 151
 49 139
 17 134
 33
Calcium (mg/dl) 11
 1 10
 1 10
 1 10
 0.4
a Hematological parameters from peripheral blood were measured at day12 of TAM treatment, while serum parameters were assessed at day14 (n 6 and 20 for
hematological and biochemical studies, respectively). , P	 0.05 for Sos1/2 DKO mice versus the rest of the groups; , P	 0.01 for Sos1/2 DKO mice versus the rest of the
groups; #, P	 0.05 for Sos2 KO mice versus Sos1 KO mice; §, P	 0.05 for Sos1 KO mice versus control mice.
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pared to WT mice, as previously described (7). In contrast, com-
bined disruption of Sos1 and Sos2 rapidly showed dramatic effects
by strongly affecting the external phenotype of adult mice. Thus,
Sos1/2 DKO mice showed dramatic body size reduction associ-
ated with an emaciated, runted appearance and had a markedly
hunched upper back, limb weakness, and shaky body movements
(Fig. 1D). Detailed body weight measurements (Fig. 1E) also re-
vealed similar values for the WT, Sos1 single-KO, and Sos2 sin-
gle-KO animals after 2 weeks of TAM induction. In contrast, the
Sos1/2 DKO mice exhibited progressive body weight reduction,
which was visible immediately after TAM administration had
been started (Fig. 1D and E). This translated into a significantly
compromised overall survival of the Sos1/2DKOmice; all of them
died around 2 weeks after TAM induction, whereas single disrup-
tion of the Sos1 or Sos2 isoforms did not affect viability in adult
mice, even after very long periods of TAM induction (Fig. 1F).
These results indicate that, despite the embryonic lethality of Sos1
null mice (6), depletion of Sos1 does not affect viability during
adulthood and the remaining, resident Sos2 can substitute for
Sos1 in those animals. However, concomitant deletion of both Sos
isoforms is absolutely critical for adult mouse survival, indicating
that expression of Sos1 or Sos2 alone is required and also sufficient
for adult mouse viability.
Blood analysis of Sos1 or Sos2 single-KO animals did not show
any significant alterations of various blood parameters, except for
the platelet counts, which appeared to be significantly increased in
Sos1/2DKOmice versus both theWTand the single-Sos-deficient
groups (Table 2). In addition, Sos2-deficient mice showed an in-
creased total number of platelets versus Sos1 KO mice (Table 2).
Conversely, combined disruption of Sos1 and Sos2 resulted in a
50% reduction in the white blood cell (WBC) count compared
to WT controls (P 0.03) (Table 2). Such reduced WBC counts
were mostly due to a significant drop in the total number of lym-
phocytes to less than one-third of WT values (P  0.002) (Table
1); the absolute counts of other WBC populations remained al-
most unaltered (P 0.05) (Table 2).
Similar to blood cell counts, normal serum biochemical pa-
rameters were also found for mice with a single deficiency in Sos1
or Sos2 versus control WT mice, as they did not exhibit any ab-
normal values (Table 2). In contrast, Sos1/2 DKO mutants
showed significantly reduced levels of total serum proteins and
albumin, together with increased serum levels of lactate dehydro-
genase (LDH), creatinine phosphokinase (CPK), and liver en-
zymes (e.g., alkaline phosphatase [ALP], glutamic pyruvic
transaminase [GPT], and glutamic-oxaloacetic transaminase
[GOT]), suggesting the occurrence of liver failure in these ani-
mals. Other biochemical parameters related to fatty acid or carbo-
hydrate metabolism remained mostly unaltered in the Sos1/2
DKO mice (Table 2).
Necropsies performed after TAM induction in all experimental
groups did not show any evident signs of gross internal organ
alteration in the Sos1 or Sos2 null mutants (versus WT controls).
Strikingly however, the Sos1/2 DKOmice showed a marked, pro-
gressive size reduction of both the thymus (this organ was almost
gone) and spleen, compared to WT animals (Fig. 1G), in the ab-
sence of any visible morphological alteration (versusWTmice) of
the hearts, lungs, kidneys, livers, or brains of these DKO animals.
Although other organ and tissue functions may also be af-
fected, the above observations focused our initial studies on a
more detailed examination of lymphoid organs (thymus and
spleen) in our Sos KO animals. In this regard, we observed a sig-
nificant weight reduction of the thymi extracted from both single
and double Sos null mutants compared toWT controls, from day
6 of TAM treatment onwards. Of note, at days 9 and 12 of
TAM feeding (when Sos1 deletion is complete), the weights of the
thymi of Sos1/2 DKO mutants were significantly lower (P 
0.008) than those of similarly treated Sos1 or Sos2 single-KOmice
(Fig. 1H). In turn, only the spleen weights of both Sos2 single-KO
mice and Sos1/2 DKOmice showed statistically significant differ-
ences versus those ofWT control mice after 9 and 12 days of TAM
induction but not at day6 (Fig. 1I).
Histological examination of the thymus and spleen did not
TABLE 3 Distribution of the major subpopulations of BM cells in WT control and Sos null mutant mice
Cell typea Genotype
Mean %
 SDb on TAM treatment day:
6 9 12
BM lymphocytes (FSClo SSClo CD11b CD117 TER119) Control 20
 4 22
 12 15
 2
Sos1/2 DKO 19
 3 11
 3 12
 2
Sos1 KO 17
 5 16
 4 14
 3
Sos2 KO 23
 4 12
 5 16
 2
Granulomonocytic cells (FSCint/hi SSCint/hi CD11b CD117 TER119) Control 47
 11 40
 9 50
 12
Sos1/2 DKO 30
 8* 27
 5* 23
 9*
Sos1 KO 42
 12 36.4
 10 26
 7*
Sos2 KO 39
 6 35
 9 29
 4*
BM erythroid cells (FSClo SSCint/hi CD11b CD117 TER119) Control 33
 8 38
 13 34
 10
Sos1/2 DKO 51
 8* 62
 7* 58
 17*
Sos1 KO 38
 11 48
 12# 59
 9*
Sos2 KO 37
 8● 52
 11 49
 11*
BM progenitors (FSClo/int SSClo/int CD11b CD117 TER119) Control 3.7
 1 2
 1 3
 0.3
Sos1/2 DKO 1.4
 0.3* 0.8
 0.2* 2
 0.9*
Sos1 KO 1.9
 0.5* 1.3
 0.5*● 1.4
 0.2*
Sos2 KO 1.9
 0.4* 1.3
 0.6*● 1.4
 0.4*
a FSC, forward light scatter; SSC, sideward light scatter; lo, low; hi, high; int, intermediate.
b , P	 0.05 versus control; ●, P	 0.05 versus Sos1/2 DKO (n 5 for control and Sos1 or Sos2 single-KO mice; n 7 for Sos1/2 DKO mice).
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show any obvious abnormalities in the Sos1 or Sos2 single-KO
animals versus WT controls but documented very significant
morphological alterations in the same organs of the Sos1/2 DKO
mice (Fig. 1J and M). In particular, H&E staining of paraffin sec-
tions showed a marked disruption of the germinal centers of the
spleen (Fig. 1J versus K) and the cortex of the thymus (Fig. 1L
versus M) of Sos1/2 DKO animals versus WT mouse organs. In
addition, a marked enhancement of cell death was found both in
the spleens and the thymi of the Sos1/2 DKO mutants by the
TUNEL assay (Fig. 1N and Q). These findings, together with the
remarkable drop of PB lymphocyte counts found in the Sos1/2
DKOanimals, warranted further examination of the developmen-
tal process of T- and B-lymphocyte progenitors in the BM, as well
as any possible alterations of their respectivematuration processes
in the thymus, spleen, and PB.
BM early progenitor cell populations are differentially af-
fected in Sos1 or Sos2 single-KOmice versus Sos1/2 DKOmice.
Multiparameter flow cytometry analysis of the distribution of dif-
ferent subpopulations of hematopoietic cells in the BM (23) of
TAM-treated control and KO animals revealed significant
changes among Sos1/2 DKOmice. These consisted of a significant
relative decrease from day 6 onwards of Sca1 CD117 BM
FIG 2 Bone marrow progenitor populations in Sos KOmice by analysis of single Sca1 and/or CD117 cells. Shown are representative density dot plots of BM
progenitors including hematopoietic stem cells (Sca1CD117 cells), commonmyeloid precursors (Sca1CD117CD19 TER119 cells), B-cell progenitors
(Sca1 CD117 CD19 TER119 cells), and early erythroid precursors (Sca1 CD117 CD19 TER119 cells) from WT control mice and both double and
single Sos mutants 6, 9, and 12 days after TAM feeding. The mean percentages 
 standard deviations (SD) are shown for each cell population. Statistically
significant differences are indicated as follows: , P	 0.05 versus control mice; , P	 0.01 versus control mice; ●, P	 0.05 versus Sos1/2 DKOmice; ●●, P	
0.01 versus Sos1/2DKOmice; #,P	 0.05 versus Sos1mice (n 5 for control and Sos1 or Sos2 single KOmice; n 7 for Sos1/2DKOmice). PC1 and -2, principal
components 1 and 2.
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progenitors and granulomonocytic cells at the expense of an in-
crease of erythroid cells, with similar B-cell (CD19) numbers
versus WT control animals (Table 3). Similar changes were also
found after longer periods of TAM treatment in the BMof Sos1 or
Sos2 single-KO mice (Table 3).
A more detailed analysis of early Sca1 CD117 BM precur-
sors in controlWTmice showed that they represented around 3 to
4% of the whole cellularity, independently of prolonged TAM
treatment (Table 3). By contrast, both Sos1 or Sos2 single-KO and
Sos1/2 DKO mice displayed a significantly marked reduction
(50%) of the size of this pool of early Sca1 CD117 progeni-
tors versus WT animals (Table 3). In more detail, fluorescence-
activated cell sorter (FACS) analysis revealed that, while the dif-
ferent subpopulations within this pool of early progenitors (e.g.,
Sca1 CD117 CD19 TER119 common myeloid precursors,
CD19 B-lymphoid progenitors, Sca1 CD117 hematopoietic
stem cells [HSC], and TER119 early erythroid precursors) were
not affected by TAM treatment in control WT mice, they were
variably impacted by the Sos1 and/or Sos2 protein deficiency (Fig.
2), the specific changes observed depending on the genotype and
the duration of the TAM treatment period (Fig. 2). Accordingly,
whereas the Sos1 and Sos2 single-KOmice exhibited rather paral-
lel patterns of fluctuation in the percentage of each subpopulation
of BM precursors at the times evaluated, the Sos1/2 DKO mice
showedmore-dramatic changes, which specifically targeted B-cell
progenitors (Fig. 2). Indeed, at day 12 of TAM treatment, the
percentage of CD19 B-cell progenitors within the overall com-
partment of Sca1 CD117 precursors in the BM of Sos1/2 DKO
mice had dropped by almost 10-fold versus WT controls (Fig. 2).
A more detailed analysis of the distinct B-cell maturation com-
partments in mice BM (e.g., CD117 Sca1 CD19 B220 IgM
pro-B cells, CD117 Sca1 CD19 B220 IgM pre-B cells,
CD117 Sca1 CD19 B220 IgM immature B cells, and
CD117 Sca1 CD19 B220 IgM recirculating B cells) (Table
4) revealed that the overall drop of B-cell progenitors in Sos1/2
DKO mice was mostly due to severe reductions of pro-B (85%
to 90%reduction) andpre-B (40%reduction) cells. Such reduc-
tions specifically occurred in animals devoid of both Sos1 and
Sos2, while they were absent in the Sos1 or Sos2 single-knockout
animals (Table 4). No significant changes were found in DKO
animals in overall percentage of BMB cells, which could be due to
the fact that both pro-B and pre-B cells accounted for only a small
proportion of all BM B cells.
Changes in the relative abundances of other subpopulations of
BMprogenitor cells linked to the single or combined disruption of
Sos1 or Sos2 were less dramatic than those described above for the
B-cell progenitors. In this regard, it should be noted that the ob-
served percent differences between single-KO animals and Sos1/2
DKO mice regarding the relative number of common myeloid
precursors after 9 or 12 days of TAM treatment (Fig. 2) may be
due, in part, to the more pronounced drop of B-cell progenitors
observed in the Sos1/2 DKO versus single-KO mice. Since Sos1
and Sos2 single-KO mice showed similar and parallel changes in
the percentages of B-cell progenitors under TAM treatment, we
may rule out a preferential involvement of either isoform in caus-
ing the overall decrease in the numbers of B-cell precursors seen in
the Sos1/2 DKOmice. Likewise, the rather parallel behavior of the
moderate changes observed in the distributions of the BM com-
partments of hematopoietic stem cells from Sos1 and Sos2 sin-
gle-KO animals (Fig. 2) also suggest that there is no preferential
contribution made by one isoform or the other to the overall dif-
ferences shown by the Sos1/2 DKO mice in comparison to WT
controls.
Sos1 is the prevalent Ras-GEF during thymocytematuration
prior to T-cell receptor (TCR) signaling. BM early T-cell precur-
sors migrate to the thymus, where they undergo a receptor-driven
maturation process and ultimately become immunocompetent T
cells. Because BM T-cell progenitors are not yet easily identifiable
by flow cytometry, our analysis of both the early and late stages of
T-cell development was fully focused on thymicmaturation, from
TABLE 4 Distribution of the different maturation-associated B-cell subsets in the bone marrow of control and Sos mutant mice
Maturation stage Group
Mean %
 SDa on TAM treatment day:
6 9 12
Pro-B cells (CD117 Sca1 TER119 CD11b CD19 B220 IgM) Control 5.6
 3.2 4.73
 0.7 7.7
 2
Sos1/2 DKO 3.8
 0.4 5
 3.1 0.9
 1.3**
Sos1 KO 5.6
 1.4 2.3
 1.7* 5.2
 1.2●●
Sos2 KO 4
 1 2.7
 1.3* 3.4
 1.4●
Pre-B cells (CD117 Sca1 TER119 CD11b CD19 B220 IgM) Control 70
 6 59
 7 66
 4
Sos1/2 DKO 70
 5 49
 9 27
 14**
Sos1 KO 66
 7 59
 12 71
 5●●
Sos2 KO 65
 3 58
 8 63
 16●●
Immature B cells (CD117 Sca1 TER119 CD11b CD19 B220 IgM) Control 18
 2 23
 3 18
 4
Sos1/2 DKO 19
 3 24
 3 21
 8
Sos1 KO 18
 2 20
 2 18
 3
Sos2 KO 20
 2 22
 4 19
 3
Recirculating B lymphocytes (CD117 Sca1 TER119 CD11b CD19 B220 IgM) Control 7
 4 13
 5 9
 5
Sos1/2 DKO 8
 3 22
 10 51
 19**
Sos1 KO 11
 6 20
 14 6
 3●●
Sos2 KO 11
 5 18
 5 15
 9●●
a Values correspond to the percentages of each cell subset from all CD19 BM B cells. , P	 0.05 versus control; , P	 0.01 versus control; ●, P	 0.05 versus Sos1/2 DKO; ●●,
P	 0.01 versus Sos1/2 DKO (n 5 for control and single Sos1 or Sos2 KO mice; n 7 for Sos1/2 DKO mice).
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the early stages of CD4 CD8 double-negative (DN) thymocytes
(DN1 to DN4) to the following more advanced stages of matura-
tion of CD4 CD8 double-positive (DP) and CD4 or CD8 single-
positive (SP) thymocytes (Fig. 3).
Overall, assessment of absolute thymocyte counts showed sim-
ilar, significant reductions by 50% in Sos1 or Sos2 single-KO an-
imals. Such decreases became much more pronounced (between
80 and 90%) in the So1/2 DKO mice (Table 5), an observation
which is consistent with the loss of weight of the thymus among
Sos1/2 DKO mice described above (Fig. 1). In detail, the overall
number of DN cells was significantly reduced in Sos1/2 DKO and
Sos1 single-KO mice in comparison to WT mice (P  0.004 and
P 0.009, respectively). In contrast, no significant changes were
detected in the number of DN thymocytes in Sos2 single-KOmice
(Fig. 3; Table 5). Characterization of individual subpopulations of
DN thymocytes in all four experimental groups documented a
FIG 3 Effect of Sos disruption on thymocyte maturation. (A) Quantitation of CD4 CD8 double-negative (DN) thymocytes, CD4 CD8 double-positive (DP)
thymocytes, CD8 single-positive cells (SP8), CD4 single-positive cells (SP4), and TCR-positive T cells in the thymi ofWT control mice, Sos1/2 DKO and Sos1
or Sos2 single-KO mice after 12 days of TAM treatment. Boxes extend from the 25th to the 75th percentiles. The line in the middle of each box and the vertical
lines represent median values and both the 10th and 90th percentiles, respectively. (B) Distribution of DN subpopulations in the thymi of control, Sos1/2 DKO,
and Sos1 or Sos2 single-KOmice after 12 days of TAM treatment. Boxes extend from the 25th to the 75th percentiles; the line in the middle and the vertical lines
represent median values and both the 10th and 90th percentiles, respectively. (C) Flow cytometry dot plots gated on DN thymocytes illustrating the pattern of
expression for CD44 and CD25 in the different subsets of DN thymocytes, DN1 (CD44 CD25), DN2 (CD44 CD25), DN3 (CD44 CD25), and DN4
(CD44CD25), frommice treatedwithTAMfor 12 days. ,P	 0.05 versus controlmice; ,P	 0.01 versus controlmice;●,P	 0.05 versus Sos1/2DKOmice;
●●, P	 0.01 versus Sos1/2 DKO mice (n 5 for control and Sos1 or Sos2 single-KO mice; n 7 for Sos1/2 DKO mice).
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severe reduction of every single subpopulation of DN thymocytes
(DN1 to DN4) in the Sos1/2 DKO animals versus WT controls
(Fig. 3; Table 5), with a particularly significant reduction of the
DN4/DN3 thymocyte ratio (Fig. 3). These results suggest the ex-
istence of amaturation blockade at pre-TCR signaling in theDKO
animals. Interestingly, Sos1 single-KO mice also showed signifi-
cantly reduced absolute numbers of each subset of DN thymo-
cytes, at levels higher than those observed in the Sos1/2 DKO
animals (Fig. 3; Table 5). In contrast, Sos2 single-KOmice showed
normal DN thymocyte numbers for all DN subsets, with the ex-
ception of a slight reduction of DN1 cells (Fig. 3; Table 5). Since
single Sos1 disruption caused a marked reduction of all DN pop-
ulations, whereas depletion of Sos2 did not significantly affect
these populations of thymocytes, our observation would support
the notion that Sos1 is the prevalent Ras-GEF involved in the
initial steps of thymocytematuration.However, since the negative
impact of Sos1 KO on DN thymocyte numbers was enhanced in
the Sos1/2 DKO mice, some functional overlapping of both Sos
isoforms may still occur during this process.
When assessingmore-mature thymocyte subpopulations, our re-
sults showed that the absolute counts of theDP, SP, andTCR cell
populationswere significantly reduced in all Sos nullmice versusWT
mice (Fig. 3; Table 5). Such decreases were more pronounced in
Sos1/2 DKO mice than in Sos1 and Sos2 single-KO mice. Sos1/2
DKO mice also showed a significantly reduced DP/DN thymocyte
ratio, indicating that thymocyte expansion from the DN to the DP
stage was markedly decreased in these mice versus WT controls but
not in the Sos1 or Sos2 null single mutants (Fig. 3; Table 5).
T-cell numbers in secondary lymphoid tissues are altered
only by simultaneous disruption of Sos1 and Sos2. After matu-
ration, T cells leave the thymus, finding their way to secondary
lymphoid tissues such as lymph nodes and the spleen through PB.
To complete the phenotypic characterization of lymphoid T cells
in our KO mice groups, we also evaluated the distribution of T
cells in the PB and spleen from all experimental groups. Overall,
our results showed highly similar patterns of distribution of total
T cells and their major CD4 CD8 and CD4 CD8 subsets in
the PB and spleens of single-KO and WT control mice. Con-
versely, Sos1/2DKOmice showed a significant reduction (by one-
half) of these T-cell populations in absolute numbers both in the
spleen and in PB (Fig. 4A; Table 6).
Sos1 and Sos2 cooperation during peripheral B-cell develop-
ment and homeostasis. In mice, maturing B cells leave the BM
through PB and they undergo further BCR-mediated differentia-
tion (24) to naive B cells in the spleen. Overall, no significantly
different splenic B-cell counts were found in Sos1 or Sos2 sin-
gle-KO mice and WT control mice. Despite this, individual mice
with Sos1 or Sos2KOgenotypes displayed a statistically significant
reduction of transitional type 2 B-cell (BT2) numbers versus WT
animals (Fig. 4B; Table 7). In contrast, Sos1/2 DKOmice showed
substantial reductions of both the overall B-cell counts and the
numbers of each individual B-cell population (Fig. 4B; Table 7).
Analysis of circulating B cells in the PB of Sos single-KO mice
showed a pattern parallel to that found in the spleen (Fig. 4B;
Table 7). In turn, Sos1/2DKOmice showed amarked reduction of
the overall number of PB B cells associated with a significant de-
crease of each of the different BT subpopulations of transitional B
cells versus WT controls, an observation which is consistent with
the depletion of B-cell production observed in the BM (Fig. 4B;
Table 7).
BM transplantation assays provide mechanistic insights for
the phenotypic alterations of Sos1/2 KO mice. In order to gain
functional insights into the mechanisms underlying the altera-
tions of survival/homeostasis and the developmental defects of
BM progenitor cells and hematopoietic cell lineages observed in
our Sos1/2 KO mice, we performed a complete set of BM trans-
plantation assays (seeMaterials andMethods) involving 4 distinct
combinations of receptor/donor genotypes (control/control,
DKO/DKO, control/DKO, and DKO/control) (Fig. 5 and 6;
Tables 8 to 11).
In this regard,we observed that engraftment ofWTcontrol BM
cells into DKO recipient mice was not sufficient to rescue the
animals from rapid death, as they died after around 15 days of
TAM treatment, showing the same time course of death as the
DKO/DKO group (data not shown). Indeed, these animals
showed a similar pattern of weight loss and comparable organ/
body weight ratios, for both thymus and spleen, to those found in
Sos1/2 DKO mice (data not shown), indicating that defects in
lymphopoietic precursors from the BM were not the primary
cause of death of DKO mice. Consistent with this, transplant of
BM from DKO mice into WT controls (control/DKO) did not
TABLE 5 Distribution of different subsets of thymocytes and T cells in the thymi of day12 TAM-treated control and Sos null mutant micea
Subset
Mean no. of cells
 SDb (103) from group:
Control Sos1/2 DKO Sos1 KO Sos2 KO
Total leukocytes 78,197
 12,134 10,732
 10,600** 37,813
 8,177**●● 39,786
 14,090**●●
DN1 87.5
 24.2 20.7
 23.6* 52
 12*● 50
 12*●
DN2 713
 334 69.4
 67.1** 264
 55**●● 453
 200●●
DN3 612
 223 76.8
 75** 266
 50**●● 430
 226●●
DN4 515
 198 40.7
 62.5** 270
 103**●● 325
 180●●
DN 1,927
 764 207
 218** 874
 206**●● 1,258
 608●●
DP 62,565
 11,205 4,390
 6,662** 31,153
 6,450**●● 31,395
 11,159**●●
CD4 CD8 SP 3,061
 717 826
 438** 1,266
 510** 1,698
 706*
CD4 CD8 SP 10,350
 1,434 2,657
 1,473** 4.392
 1,220**● 5,247
 1,847**
TCR T cells 296
 65 56
 27** 143
 52**● 188
 66*●●
a Each subpopulation was specifically identified by flow cytometry using the following antibody mixture: CD3ε, CD4, CD5, CD8a, CD24, CD25, CD44, TCR, and TCR. DN,
CD4 CD8 double-negative thymocytes; DP, CD4 CD8 double-positive thymocytes; SP, single-positive thymocytes.
b , P	 0.05 versus control; , P	 0.01 versus control; ●, P	 0.05 versus Sos1/2 DKO mice; ●●, P	 0.01 versus Sos1/2 DKO mice (n 5 for control and Sos1 or Sos2 single-KO
mice; n 7 for Sos1/2 DKO mice).
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affect the overall survival rate of the recipient WT mice, and no
phenotypic alterations were detected (data not shown).
Likewise, transplantation of healthy BM cells did not recover
the defects of B-cell progenitors observed in the DKOmice. Thus,
in line with the quantitative data shown in Tables 1 and 2, early
Sca1 CD117 BM precursors in control/control transplanted
animals represented around 2 to 3% of the whole BM cellularity;
in contrast, the DKO/DKO transplanted mice displayed a signifi-
cantly marked reduction (50%) of the size of this pool of early
Sca1 CD117 progenitors versus the control/control trans-
planted animals. In addition (consistent with Fig. 2), similar un-
changed levels of early erythroid precursors were found among
the four experimental groups (Fig. 5A). Interestingly, the percent-
age of commonmyeloid precursors (CMP) was increased in both
DKO/DKO and DKO/control mice versus both control/control
and control/DKO transplanted mice, and this increase was ac-
companied by a marked reduction in the percentage of CD19
B-cell progenitors in both the DKO/DKO and DKO/control
groups (Fig. 5A). Detailed analysis of the distinct B-cell subpopu-
lations revealed that the overall drop of this cell compartment in
DKO/control and DKO/DKO transplanted mice was mostly due
to a marked decrease in the percentage of pre-B cells (Table 8). In
addition, the percentage of pro-B cells significantly dropped in
DKO/control transplanted mice versus the control/control and
control/DKO groups (Table 8). No significant changes were
found in the percentages of immature BMB cells among all exper-
imental groups versus control/control transplanted mice. In con-
trast, the percentage of recirculating B cells was higher in all
groups than in control/control mice (Table 8). Moreover, this
subset was significantly enhanced in both the DKO/control and
FIG 4 Effect of Sos disruption onmature T- and B-cell populations from the spleen and peripheral blood. (A)Quantitation of total T lymphocytes, CD4CD8
and CD4 CD8 T cells isolated from the spleens and from peripheral blood fromWT control, Sos1/2 DKO, and Sos1 or Sos2 single-KO mice after 12 days of
TAM treatment. (B) Quantitation of total B lymphocytes and B-cell subsets in the spleens and peripheral blood from control, Sos1/2 DKO mutant, and Sos
single-KOmice after 12 days of TAM treatment. Boxes extend from the 25th to the 75th percentiles; the line in themiddle and the vertical lines representmedian
values and both the 10th and 90th percentiles, respectively. ,P	 0.05 versus controlmice; ,P	 0.01 versus controlmice;●,P	 0.05 versus Sos1/2DKOmice;
●●, P	 0.01 versus Sos1/2 DKO (n 5 for control and Sos1 or Sos2 single-KO mice; n 7 for Sos1/2 DKO mice). BT1 to -3, type 1 to 3 transitional B cells.
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DKO/DKO groups compared to control/DKO mice (Table 8).
These differences may be due, at least in part, to the more pro-
nounced drop of pre-B cells observed in the first two groups.
The effects of the different BM transplantation conditions on
thymocyte maturation were also examined (Fig. 5B and C; Table
9). Thus, the absolute thymocyte count showed a slight significant
reduction in control/DKO transplantedmice relative to control/con-
trol mice, and the decrease was much more marked (about 75%) in
both the DKO/control and DKO/DKO groups (Table 9). Regarding
specific thymocyte subpopulations, the overall number of DN cells
was significantly reduced in all DKOgroups (control/DKO,DKO/
control, and DKO/DKO) versus control/control transplanted
mice. In addition, the number of DN cells in control/DKO mice
was significantly higher than those detected in DKO/DKO and
DKO/control groups (Fig. 5B; Table 9). Quantitation of DN thy-
mocyte subpopulations in all four experimental transplanted
groups showed reductions of every single subpopulation in con-
trol/DKO, DKO/control, and DKO/DKO transplanted mice ver-
sus the control/control group (Fig. 5C; Table 9). Interestingly,
these reductions weremore pronounced in both theDKO/control
and DKO/DKO mice than in the control/DKO group (Fig. 5C;
Table 9). As previously observed in Sos1/2 DKO animals, the
DN4/DN3 ratio was significantly reduced in both the DKO/con-
trol andDKO/DKO transplantedmicewith respect to the control/
control and control/DKO groups (Fig. 5C).
The absolute counts of theDP thymocyte populations revealed
a significant reduction in all control/DKO, DKO/control, and
DKO/DKO transplanted mice versus the control/control group
(Fig. 5B; Table 9). In addition, this drop was more pronounced in
the DKO/control and DKO/DKO groups than in the control/
DKO transplantedmice (Fig. 5B; Table 9). Interestingly, when the
mostmature thymocyte stages were compared, our results did not
show any significant differences in the CD8 SP and CD4 SP pop-
ulations among all four experimental groups (Fig. 5B; Table 9).
Finally, the distribution of mature T and B cells in the
spleens and PB of our transplanted animal groups was checked
(Fig. 6). Overall, our results showed no significant differences
among all experimental groups regarding the total number of T
cells or their main CD4 SP and CD8 SP subsets in spleens or PB
(Fig. 6A; Table 10).
The total number of splenic B cells was significant lower in
the control/DKO, DKO/control, and DKO/DKO groups than in
TABLE 6 Distribution of mature T cells in the spleens and peripheral blood of day12 TAM-treated control and Sos null mutants
Parameter
Value (mean
 SD)a for mouse group:
Control Sos1/2 DKO Sos1 KO Sos2 KO
No. of leukocytes (103) 51,413
 16,964 20,978
 7,434* 39,030
 7,428● 32,832
 4,074●
No. of leukocytes/l of PBb 3,347
 1,795 1,128
 889* 3,390
 395● 2,695
 984●
No. of spleen T cells (103)
Total 23,604
 6,674 12,563
 6,018* 23,819
 6,000● 18,110
 1,927●
CD4 CD8 13,992
 4,535 7,403,7
 3,319* 14,363
 3,432● 11,009
 1,621●
CD4 CD8 6,870
 1,651 4,462
 2,636 7,951
 2,187● 6,005
 592
No. of PB T cells/l
Total 1,060
 452 320
 206* 1,305
 205●● 998
 319●
CD4 CD8 709
 325 202
 142* 824
 150●● 647
 188●
CD4 CD8 213
 87 75
 39* 313
 69●● 315
 49●
a , P	 0.05 versus control; ●, P	 0.05 versus Sos1/2 DKO mice; ●●, P	 0.01 versus Sos1/2 DKO mice (n 5 for control and Sos1 or Sos2 single-KO mice; n 7 for Sos1/2
DKO mice).
b PB, peripheral blood.
TABLE 7 Distribution of B-cell subsets in the spleens and the peripheral blood of day12 TAM-treated control and Sos null mutant micea
Parameterb
Value (mean
 SD)c for mouse group:
Control Sos1/2 DKO Sos1 KO Sos2 KO
No. of leukocytes (103) 51,413
 16,964 20,978
 7,434* 39,030
 7,428● 32,832
 4,074●
No. of leukocytes/l PB 3,347
 1,795 1,128
 889* 3,390
 395● 2,695
 984●
No. of B cells (103)
Total B cells 17,153
 4,684 7,325
 1,742** 11,689
 3,061● 12,320
 1,768●●
BT1 (CD19 B220 IgM IgD CD21 CD23 CD24) 4,115
 1,886 481
 457** 2,554
 627●● 2,539
 1,361●●
BT2 (CD19 B220 IgM IgD CD21 CD23 CD24) 4,142
 1,265 1,067
 474** 1,755
 483**● 2,079
 406**●●
BT3 (CD19 B220 IgM IgD CD21 CD23 CD24) 6,025
 1,007 3,579
 977** 4,948
 2,419 5,421
 728●●
No. of PB B cells/l
Total B cells 634
 309 157
 128* 863
 682●● 682
 335●
BT1 94
 38 17
 15* 171
 74*●● 141
 96●
BT3 528
 269 134
 119* 657
 284●● 532
 252●
a Each BT subpopulation was identified by flow cytometry.
b BT1, -2, and -3, type 1, 2, and 3 transitional B cells; PB, peripheral blood.
c , P	 0.05 versus control; , P	 0.01 versus control; ●, P	 0.05 versus Sos1/2 DKO mice; ●●, P	 0.01 versus Sos1/2 DKO mice (n 5 for control and Sos1 or Sos2 single-KO
mice; n 7 for Sos1/2 DKO mice).
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FIG 5 (A to C) Distribution of distinct subsets of Sca1 and/or CD117 progenitors and precursors cells (A), thymocytes (B), and CD4 CD8 double-negative
thymocytes in the bone marrow (A) and the thymi (B and C) of transplanted mice. (A) Representative multivariate analysis (principal component analysis)
density plots of different subsets of BM progenitors, including Sca1 CD117 hematopoietic stem cells (green), Sca1 CD117 CD19 TER119 common
myeloid precursors (orange), Sca1CD117CD19TER119B-cell progenitors (blue), and Sca1CD117CD19TER119 early erythroid precursors (pink)
from the four groups of transplanted mice (transplant receptor/transplant donor: control/control, DKO/DKO, control/DKO, and DKO/control mice) 12 days
after TAM feeding. The mean percentages 
 SD are shown for each cell population. PC1 and -2, principal components 1 and 2. (B) Number of CD4 CD8
double-negative (DN) thymocytes, CD4 CD8 double-positive (DP) thymocytes, CD8 single-positive cells (SP8), CD4 single-positive cells (SP4), and TCR-
positive T cells in the thymi of control/control, DKO/DKO, control/DKO, and DKO/control mice after 12 days of TAM treatment. (C) Distribution of the
different subpopulations of DN thymocytes in the thymi of control/control, DKO/DKO, control/DKO, and DKO/control mice after 12 days of TAM treatment.
In panels B and C, boxes extend from the 25th to the 75th percentiles; the line in the middle and the vertical lines represent median values and both the 10th and
90th percentiles, respectively. Statistically significant differences are indicated as follows: , P 	 0.05 versus control/control group; , P 	 0.01 versus
control/control group; ●, P	 0.05 versus DKO/DKO mice; ●●, P	 0.01 versus DKO/DKO mice; #, P	 0.05 versus control/DKO group; ##, P	 0.01 versus
control/DKO group (n 7 for control/control, DKO/DKO, and DKO/control mice; n 10 for control/DKO mice).
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the control/control mice; this reduction was more marked in the
DKO/DKOmice with respect to the control/DKO group (Fig. 6B;
Table 11). More-detailed analysis of splenic B-cell subsets showed
that decreased B-cell numbers in all three groups were mainly
attributed to the BT2 subpopulation (Fig. 6B; Table 11). In addi-
tion, the BT1 and BT3 subsets were also diminished inDKO/DKO
mice versus control/control transplantedmice (Fig. 6B; Table 11);
these subpopulations remained unaltered both in the control/
DKO and DKO/control groups versus control/control mice (Fig.
6B and Table 11). Analysis of total circulating B cells in PB showed
a slight reduction in control/DKO transplanted mice versus the
control/control group (Fig. 6B; Table 11). Interestingly, the num-
bers of immature BT1, but not of BT3, B cells were significantly
reduced in the DKO/DKO, control/DKO, and DKO/control ex-
perimental groups with respect to control/control transplanted
mice (Fig. 6B; Table 11).
DISCUSSION
Here, we describe the generation and features of the first available
mouse model where the functional effects of full-body expression
of a Sos1 null mutation could be studied in adult animals. Previ-
ous work from our group showed that constitutive Sos1 KOmice
died during midgestation whereas adult Sos2 knockout mice are
viable and fertile (4, 6, 7). To overcome the embryonic lethality of
Sos1 null mutation, here we produced TAM-inducible Sos1 KO
mice capable of expressing the Sos1 null mutation throughout the
adult body. We then bred these mice to Sos2 KOmice to generate
a Sos1/2 DKO strain, which would allow direct analysis of the
functional specificity versus redundancy of both isoforms of Sos in
the adult organism and its tissues and cell lineages, an issue that
could not be easily approached without this new animal model.
Overall, our observations showed that adult animals harboring a
disrupted Sos1 locus throughout the body were as viable as the
FIG 6 Effect of Sos disruption on mature T- and B-cell populations from the spleens of transplanted mice after 12 days of TAM treatment. (A) Numerical
distribution of total T lymphocytes and the major CD4 CD8 and CD4 CD8 T-cell subsets isolated from the spleens and from the peripheral blood of
different groups of transplanted mice (transplant receptor/transplant donor: control/control, DKO/DKO, control/DKO, and DKO/control mice). (B) Numer-
ical distribution of total B lymphocytes and their major subsets (BT1, BT2, and BT3, type 1, 2, and 3 transitional B cells, respectively) in the spleens and the
peripheral blood of the control/control, DKO/DKO, control/DKO, and DKO/control groups of transplanted mice. In both panels, boxes extend from the 25th
to the 75th percentiles; the line in the middle and the vertical lines represent median values and both the 10th and 90th percentiles. Statistically significant
differences are indicated as follows: , P	 0.05 versus control/control group; , P	 0.01 versus control/control group; ●●, P	 0.01 versus DKO/DKOmice;
(n 7 for control/control, DKO/DKO, and DKO/control mice; n 10 for control/DKO mice).
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constitutive Sos2KOmice. In contrast, Sos1/2DKOadult animals
died precipitously after disruption of the Sos1 locus, indicating
that expression of a single WT Sos allele, be it the Sos1 or Sos2
allele, is required and sufficient to support full animal viability and
whole-body homeostasis of adult mice. Although serum blood
analyses uncovered clear signs of hepatic failure in the Sos1/2
DKO mice, the exact cause of death of these animals remains
unknown. The lymphopoietic defects displayed by Sos1/2 DKO
animals can be excluded as the primary cause of death, as our BM
transplantation assays showed that engraftment of BM from WT
animals into DKO mice or from DKO into WT animals did not
change in any case the original overall homeostasis and survival
rates of the recipient mouse strains, indicating that Sos1/2 disrup-
tion of all the BM cell subpopulations is not enough to compro-
mise the overall survivability of the harboring mice. Given that
Ras activation and function are critical for all ormostmammalian
cell types, it is likely that the cause of rapid wasting and death
suffered by our DKO animals is multiorgan failure, much as it
happens to Ras-less mice devoid of the 3 canonical (H, N, and K)
Ras proteins (25).
In any case, our data also showed that other Ras-GEFs ex-
pressed in the same animals are not able to substitute for themiss-
ing Sos proteins and support the notion that the embryonic lethal-
ity of Sos1 null mutation is due to placental malformation (6)
rather than to inability to sustain progress of organism develop-
mental programs.
Whereas Ras signaling is known to play a key role in the devel-
opment and differentiation of BM progenitors (26, 27), the spe-
cific involvement of different Ras-GEFs during this process re-
mains poorly understood. In particular, previous reports
indicated that Ras-mediated effector pathways are responsible for
pre-B-cell survival (28, 29), but little is known concerning the
TABLE 8 Distribution of the different maturation-associated B-cell subsets in the bone marrow of transplanted groups
Maturation stage Group
Mean %
 SDa on TAM
treatment day12
Pro-B cells (CD117 Sca1 TER119 CD11b CD19 B220 IgM) Control/control 6.3
 1.7
DKO/DKO 6.6
 6.5
Control/DKO 8.9
 3.2
DKO/control 1.2
 0.5**#
Pre-B cells (CD117 Sca1 TER119 CD11b CD19 B220 IgM) Control/control 62.3
 4
DKO/DKO 26
 17**
Control/DKO 54
 10●●
DKO/control 37
 9**##
Immature B cells (CD117 Sca1 TER119 CD11b CD19 B220 IgM) Control/control 16
 4
DKO/DKO 12
 5
Control/DKO 13
 2
DKO/control 23
 8●##
Recirculating B lymphocytes (CD117 Sca1 TER119 CD11b CD19 B220 IgM) Control/control 15
 3
DKO/DKO 54
 26**
Control/DKO 23
 9*●
DKO/control 38
 13●●##
a Values correspond to the percentages of each cell subset from all CD19 BM B cells. , P	 0.05 versus control/control; , P	 0.01 versus control/control mice; ●, P	 0.05
versus DKO/DKO mice; ●●, P	 0.01 versus DKO/DKO mice; #, P	 0.05 versus control/DKO mice; ##, P	 0.01 versus control/DKO mice (n 7 for control/control,
DKO/DKO, and DKO/control groups; n 10 for control/DKO group).
TABLE 9 Distribution of different subsets of thymocytes and T cells in the thymi of day12 TAM-treated engrafted micea
Subsetb
Mean no. of cells
 SDc (103)from group:
Control/control DKO/DKO Control/DKO DKO/control
Total leukocytes 40,483
 4,595 10,677
 9,354** 30,762
 12,717*● 17,379
 8,444**#
DN1 25.9
 10.5 9.9
 7.8* 15.3
 4.6* 13
 6.5*
DN2 385
 130 88.9
 52.7** 194
 52**●● 136
 84.9**
DN3 303
 68 71.3
 52.7** 173
 70**●● 128
 77**
DN4 605
 148 55
 75** 284
 130**●● 65
 64**##
DN 1,318
 307 225
 175** 666
 220**●● 342
 190**#
DP 32,881
 4,189 5,916
 7,130** 25,554
 10,791*●● 11,508
 6,937**##
CD4 CD8 SP 1,477
 423 1,247
 581 1,098
 452 1,280
 352
CD4 CD8 SP 4,587
 997 3,224
 1,660 3,342
 1,540 4,116
 1,306
TCR T cells 198
 42 56
 37** 97
 33**● 121
 63*●
a Each subpopulation was specifically identified by flow cytometry using the following antibody mixture: CD3ε, CD4, CD5, CD8a, CD24, CD25, CD44, TCR, and TCR.
b DN, CD4 CD8 double-negative thymocytes; DP, CD4 CD8 double-positive thymocytes; SP, single-positive thymocytes.
c , P	 0.05 vs control/control group; , P	 0.01 versus control/control group; ●, P	 0.05 versus DKO/DKO group; ●●, P	 0.01 versus DKO/DKO group; #, P	 0.05 versus
control/DKO group; ##, P	 0.01 versus control/DKO group (n 7 for control/control, DKO/DKO, and DKO/control groups; n 10 for control/DKO group).
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potential participation of Sos or other Ras-GEFs during BM lym-
phopoiesis. Here, we showed that combined depletion of Sos1 or
Sos2 resulted in a synergistic, almost complete, disappearance of
B-cell progenitors, particularly pro-B cells but also pre-B cells,
while individual depletion of the Sos genes did not. These results
suggest that the two Sos isoforms are functionally redundant dur-
ing B-cell differentiation in the BM and that no other Ras-GEFs
can significantly contribute to overcoming the absence of Sos in
this process.
Recent results indicate that inhibition of the Grb2-Sos interac-
tion downregulates Raf/MEK/extracellular signal-regulated ki-
nase (Raf/MEK/ERK) signaling and reduces HSC differentiation
(30, 31). Consistent with these findings, our data also showed that
individual disruption of either Sos1 or Sos2 leads to reduced per-
centages in the HSC compartment versus those for WT mice and
also Sos1/2DKOmice.Of note, currently availablemethodologies
allow accurate quantitation of only the relative numbers of differ-
ent BM cell subpopulations; therefore, the observed significantly
higher percentage of HSC in the BM of Sos1/2 DKOmice than in
that of single-KOmicemost likely reflects the dramatic drop in the
number of B-cell progenitors occurring in the formermice. In line
with this hypothesis, no significant reduction in the percentage of
the CMP was observed in single-KO or Sos1/2 DKO mice versus
control mice, and, in addition, the data generated in our various
BM transplantation assays for WT control and Sos1/2 DKOmice
are also consistent with this notion. Altogether, these observations
suggest that the Sos proteins are not essential for the development
andmaintenance ofmyeloid cells and are consistent with previous
results showing that macrophage colony-stimulating factor (M-
CSF)-stimulated differentiation of a murine myeloid cell line de-
pends on persistent MEK/MAPK activation but is independent of
the Grb2-Sos1 association (32).
Regarding T-cell development, here we show that Sos1 defi-
ciency causes a significant decrease of early thymocytes at all DN
stages, an observation which is consistent with previous results
demonstrating a critical role for Sos1 in early T-cell development
(8). Although Sos1 appears to be the prevalent player, it was also
reported that Sos1 and RasGRP1 cooperate during pre-TCR-me-
diated T-cell development and that Sos2 is dispensable during
pre-TCR-mediated and TCR-mediated positive or negative thy-
TABLE 10 Distribution of mature T cells in the spleen and peripheral blood transplanted groups after 12 days of TAM treatment
Parameter
Value (mean
 SD)a for mouse group:
Control/control DKO/DKO Control/DKO DKO/control
No. of leukocytes (103) 29,992
 11,964 11,395
 4,403** 18,317
 4,713*●● 19,368
 11,873*
No. of leukocytes/l of PBb 4,514
 1,734 2,713
 1,048* 3,122
 1,774 3,827
 1,401
No. of spleen T cells (103)
Total T cells 11,633
 5,079 6,402
 1,997 7,907
 1,929 9,821
 5,675
CD4 CD8 7,510
 3,179 4,000
 1,222 5,036
 1,171 6,245
 3,492
CD4 CD8 3,286
 1,575 2,087
 719 2,312
 654 2,930
 1,789
No. of PB T cells/l
Total T cells 1,284
 243 1,296
 521 1,314
 705 1,444
 707
CD4 CD8 839
 150 915
 360 861
 526 1,041
 511
CD4 CD8 308
 117 308
 159 345
 156 286
 136
a , P	 0.05 versus control/control group; , P	 0.01 versus control/control group; ●●, P	 0.01 versus DKO/DKO group (n 7 for control/control, DKO/DKO, and DKO/
control groups; n 10 for control/DKO group).
b PB, peripheral blood.
TABLE 11 Distribution of B-cell subsets in the spleen and the peripheral blood of day12 TAM-treated control/control, DKO/DKO,
control/DKO, and DKO/control groupsa
Parameterb
Value (mean
 SD)c for mouse group:
Control/control DKO/DKO Control/DKO DKO/control
No. of leukocytes (103) 29,992
 11,149 11,395
 4,030** 18,317
 4,713*●● 19,368
 11,873*
No. of leukocytes/l PB 4,514
 1,734 2,713
 1,048* 3,122
 1,774 3,827
 1,401
No. of B cells (103)
Total B cells 14,962
 5,430 4,127
 2,529** 7,940
 2,448**●● 7,625
 1,750*
BT1 (CD19 B220 IgM IgD CD21 CD23 CD24) 1,333
 1,106 153
 92* 424
 209●● 648
 376●●
BT2 (CD19 B220 IgM IgD CD21 CD23 CD24) 2,706
 1,393 624
 344** 1,066
 477** 1,476
 1,171*
BT3 (CD19 B220 IgM IgD CD21 CD23 CD24) 5,904
 3,530 2,379
 1,730* 4,741
 1,394●● 3,778
 2,211●●
No. of PB B cells/l
Total B cells 1,032
 490 538
 402 592
 395 735
 292
BT1 174
 76 36
 21** 39
 13** 45
 30**
BT3 845
 398 497
 378* 548
 393 690
 266
a Each BT subpopulation was identified by flow cytometry.
b BT1, -2, and -3, type 1, 2, and 3 transitional B cells; PB, peripheral blood.
c , P	 0.05 versus control/control group; , P	 0.01 versus control/control group; ●●, P	 0.01 versus DKO/DKO group (n 7 for control/control, DKO/DKO, and DKO/
control groups; n 10 for control/DKO group).
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mocyte development and selection (17). In this regard, our data
revealed that single Sos2 disruption did not affect early matura-
tion stages except for the DN1 subpopulation, which decreased
slightly versus WT controls. A potential explanation for such a
DN1 decrease might be a reduced input of T-cell progenitors ar-
riving from the BM. Indeed, our BM transplantation assays favor
this hypothesis, as they document a specific linkage between
Sos1/2 disruption in the transplanted BM cells and reduction of
the total number of DN thymocytes in the recipient control mice.
Surprisingly, although single Sos2 disruption did not alter early
thymocytematuration, its contribution proved to be critical in the
absence of Sos1, since the counts of all DN1 to -4 thymocyte pop-
ulations were markedly reduced in the Sos1/2 DKO mice in
comparison to the individual Sos1 or Sos2 null mutants. The
apparent discrepancy concerning the marginal versus redun-
dant role of Sos2 dispensability between our data and those
previously reported by others (17) may be explained because
the later studies were focused on maturation-stage-specific,
Lck-CRE-mediated disruption of Sos1 occurring only at the
DN2/DN3 transition, whereas in our animal model full-body
disruption of the Sos1 locus occurs. The dramatic effect of
double-Sos1/2 disruption on early thymocyte development
could also potentially be related to alterations of progenitors
arriving from the BM or dysfunction of other thymic popula-
tions involved in T-cell development such as dendritic cells. In
this regard, BM cells from Sos1/2 DKOmice caused disruption
of early thymocyte development stages after engraftment into
control mice, and, additionally, healthy BM cells engrafted into
Sos1/2 DKO mice did not palliate the defects in early thymo-
cyte development. Altogether, these results suggest that the
severe effect of early thymocyte development linked to con-
comitant Sos1/2 deficiency is a consequence, at least in part, of
(i) reduced arrival/input of cells from the BM and (ii) impaired
DN maturation at pre-TCR signaling.
Previous reports indicate that, as thymocyte maturation pro-
gresses, Sos involvement decays and RasGRP1 function becomes
prevalent at the level of TCR-mediated signaling (8, 14, 16, 33, 34),
although a recent study also reported functional cooperation be-
tween Sos1 and RasGRP1 during negative thymic selection (17).
Consistently, our results showed that the cellular expansion taking
place during the transition fromDN toDP thymocytes wasmark-
edly reduced in Sos1/2 double-null mutants but not in mice lack-
ing only one Sos isoform; such results support the notion of func-
tional redundancy between Sos1 and Sos2 to sustain expansion of
thymocytes occurring during progress through these maturation
stages. Most interestingly, our results also showed that Sos1/2
DKOwas associated with a marked decrease in the absolute num-
ber of T cells and their major CD4 CD8 and CD4 CD8
subsets both in PB and the spleen, whereas single Sos1 or Sos2
disruption did not alter mature T-cell counts in both tissues. Such
observations further point out the potential overlapping role of
the Sos isoforms during the latter stages of T-cell development,
although they could also be a consequence of the disruption or
early thymocyte maturation occurring in the DKOmice. The data
from our present BM transplantation experiments, together with
the recent demonstration of Sos-independent, TCR-mediated Erk
activation in peripheral human T cells (35), favor the second pos-
sibility, although a more definitive mechanistic answer requires
further investigations.
Similarly, analysis of the distribution ofmaturation-associated
B-cell subsets in the spleen and PB also showed that only com-
bined disruption of the two Sos proteins leads to a clear alteration
of all subsets of mature B lymphocytes but marginal-zone B cells,
except for slightly decreased BT2 counts in the spleens of Sos1 and
Sos2 single-KO mice. Since previous reports in which Erk activa-
tion during BCR-mediated B-cell maturation is analyzed support
a prevalent role in this process for RasGRP1/2 versus Sos (12, 14),
we speculate that the significantly reduced numbers of B cells de-
tected in the PB and spleens of Sos1/2 DKOmutants are mainly a
consequence of the dramatic drop in B-cell production in the BM
rather than an alteration of more-mature B-cell populations.
However, simultaneous occurrence of an altered homeostasis of
mature B cells cannot be completely ruled out, particularly be-
cause an increased rate of apoptosis in association with a signifi-
cant disruption of normal spleen histology was also observed.
In summary, herewe described the firstmousemodelwhere, to
our knowledge, the effect of full-body expression of a Sos1 null
mutation could be studied during adulthood. Our data demon-
strate functional redundancy of Sos1 and Sos2 for homeostasis
and survival of the full organism and for the development and
maturation of B and T lymphoid cells. Ascertaining the functional
properties of the Sos family members is relevant for physiological
and pathological processes in view of their role as universal GEF
activators in multiple Ras-mediated signaling pathways.
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